Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 12 of 12 for “"SLE DISEASE ACTIVITY"”.
-
Weathering the Divide: Social Determinants, Neighborhood Context, and Systemic Lupus Erythematosus Among African American Women
Background: Systemic lupus erythematosus (SLE) disproportionately affects African American women and contributes to racial health disparities in the United States. Although genetic susceptibility influences disease risk, growing evidence suggests that social determinants of health (SDOH), including …
-
ΕΠΙΠΕΔΑ Β2-ΜΙΚΡΟΣΦΑΙΡΙΝΗΣ ΣΤΟΝ ΟΡΟ ΑΣΘΕΝΩΝ ΜΕ ΣΥΣΤΗΜΑΤΙΚΟ ΕΡΥΘΗΜΑΤΩΔΗ ΛΥΚΟ ΠΡΟΣΦΑΤΗΣ ΕΝΑΡΞΕΩΣ
… 45 PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) OF RECENT ONSET (DISEASE DURATION EQUAL TO OR LESS THAN ONE YEAR) AND WITHOUT RENAL INVOLVEMENT, WHO MET THE ARA CRITERIA FOR CLASSIFICATION OF SLE (GROUP I) AND IN 14 OF THESE PATIENTS AT A TIME WHEN THEIR MEAN DISEASE DURATION WAS 5 MONTHS …
-
Development and validation of the BILAG-2004 Index for the assessment of disease activity in systemic lupus erythematosus
… the BILAG-2004 index for the assessment of disease activity in patients with [systemic lupus erythematosus] SLE had involved several validation studies. The reliability of this index was shown in 2 exercises, as assessed by level of agreement, kappa statistic, ICC and disagreement between …
-
Preliminary safety and immunogenicity of Zostavax vaccine in mild-moderately immunosuppressed systemic lupus erythematosus patients, and healthy controls
BACKGROUND: Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease affecting people of various ages across the globe. Treatment for the disease is in the form of immunosuppressive drugs. Due to either the treatment of the disease or the disease itself, SLE patients have been shown to …
-
Apoptosis of Peripheral Blood Leukocytes in Systemic Lupus Erythematosus: Studies on Serum Induction and Complement-Dependent Clearance Mechanisms
Systemic lupus erythematosus (SLE) is an autoimmune disease involving many organ systems. The cause is not known, but a complex combination of environmental and genetic factors seems to be involved. In SLE upregulation of type I interferons, a hyperactive B-cell response, presence of autoantibodies …
-
IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus
… of three biomarkers for interferon (IFN) activity (measured directly and indirectly) and six traditional biomarkers in indicating current and prospective disease activity (DA) in systemic lupus erythematosus (SLE). Methods IFNα (dissociation- enhanced lanthanide fluorescent immunoassay), …
-
Pharmaceutical outcomes research to better understand medication non-adherence in patients with Systemic Lupus Erythematosus
… (AM) in Systematic Lupus Erythematosus (SLE). AM is the conventional and effective long-term treatment option that has resulted in substantial decreases in deaths associated with SLE disease activity. However, there seems to be no such decline in the deaths associated with the sequelae of …
-
Characterization of Slit2-C as a biomarker of disease activity in systemic lupus erythematosus and lupus nephritis
Systemic lupus erythematosus (SLE) is a complex autoimmune disease with a high likelihood of renal involvement. There are several pathophysiological processes that remodel the kidney in lupus nephritis (LN). A kidney biopsy is the golden standard for classifying lupus nephritis. Commercially …
-
Functions of ARID3a in multiple hematopoietic cell types
… genome and transcriptome and identify potential disease-causing mutations, having important implications for personalized medicine. One year later, the capability to interrogate the transcriptome of a single cell became possible with the introduction of single-cell RNA-seq (scRNA-seq) (2). …
-
ΑΝΤΙΣΩΜΑΤΑ ΚΑΤΑ ΔΕΟΞΥΡΙΒΟΝΟΥΚΛΕΙΚΟΥ ΟΞΕΟΣ (DNA). ΑΝΑΠΤΥΞΗ ΚΑΙ ΣΥΓΚΡΙΣΗ ΜΕΘΟΔΩΝ ΠΡΟΣΔΙΟΡΙΣΜΟΥ, ΚΛΙΝΙΚΗ ΣΗΜΑΣΙΑ
… OF SERA OF PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES AND 119 SERA OF HEALTHY BLOOD DONORS. THE PRESENCE OF BOTH IGG AND IGM ANTI DS DNA WAS HIGHLY CORRELATED WITH SLE. IN ADDITION SERUM COMPLEMENT C3 AND C4 LEVELS CORRELATED NEGATIVELY WITH ANTI DS DNA LEVELS. FINALLY IN SEQUENTIAL SERA FROM …
-
Συσχέτιση των αρχικών εκδηλώσεων του συστηματικού ερυθηματώδη λύκου με τις εκδηλώσεις κατά την πορεία της νόσου σε περίοδο 5 ετών
Systemic lupus erythematosus (SLE) is the most clinically and serologically diverse of the autoimmune connective tissue diseases because it may affect any organ of the body. However, some studies suggest that this condition can be divided into more homogenous subsets of pathogenetic, therapeutic, …
-
Δραστηριότητα συστηματικού ερυθηματώδους λύκου: στάθμιση νεότερων ανοσολογικών παραμέτρων
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease,primarily affecting women of reproductive age. Disease incidence ranges from 1 to10/100000 persons/year, while prevalence is estimated to be 20 to 70 patients/100000population. The exact etiopathogenesis remains unknown; however it …